Growth Metrics

Omeros (OMER) Invested Capital (2010 - 2026)

Omeros recorded quarterly Invested Capital of -$63.3 million in Q1 2026, up 47.22% quarter-over-quarter from -$120.0 million in Q4 2025, and up 66.06% year-over-year from -$38.1 million in Q1 2025.

Omeros' Invested Capital history runs 17 years deep, the most recent figure standing at -$63.3 million for Q1 2026.

  • In Q1 2026, Invested Capital rose 66.06% year-over-year to -$63.3 million; the TTM figure through Mar 2026 stood at -$63.3 million (up 66.06% YoY), while the FY2025 annual figure was -$120.0 million, up 33.56% from the prior year.
  • Invested Capital came in at -$63.3 million for Q1 2026 at Omeros, up from -$120.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $180.1 million in Q4 2022 to a low of -$228.7 million in Q2 2025.
  • A 5-year average of -$54.8 million and a median of -$63.3 million in 2026 frame the typical range for Invested Capital.
  • Across the five-year window, Invested Capital surged 3135.33% in 2023 and tumbled 662.37% in 2024, its largest moves.
  • Omeros' Invested Capital stood at $180.1 million in 2022, then sank by 113.16% to -$23.7 million in 2023, then sank by 662.37% to -$180.6 million in 2024, then soared by 33.56% to -$120.0 million in 2025, then surged by 47.22% to -$63.3 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods registered -$63.3 million, -$120.0 million, and -$220.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.96 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -63.33 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -63.33 Mn
Dec 31, 2025 -120.01 Mn
Sep 30, 2025 -220.48 Mn
Jun 30, 2025 -228.69 Mn
Mar 31, 2025 -186.62 Mn
Dec 31, 2024 -180.64 Mn
Sep 30, 2024 -154.17 Mn
Jun 30, 2024 -124.60 Mn
Mar 31, 2024 -71.33 Mn
Dec 31, 2023 -23.69 Mn
Sep 30, 2023 80.96 Mn
Jun 30, 2023 115.24 Mn
Mar 31, 2023 149.49 Mn
Dec 31, 2022 180.07 Mn
Sep 30, 2022 -46.31 Mn
Jun 30, 2022 -32.70 Mn
Mar 31, 2022 -4.93 Mn
Dec 31, 2021 23.78 Mn
Sep 30, 2021 -262.70 Mn
Jun 30, 2021 -246.30 Mn
Mar 31, 2021 -221.96 Mn
Dec 31, 2020 -120.75 Mn
Sep 30, 2020 137.67 Mn
Jun 30, 2020 48.73 Mn
Mar 31, 2020 78.14 Mn
Dec 31, 2019 100.98 Mn
Sep 30, 2019 -139.92 Mn
Jun 30, 2019 -130.27 Mn
Mar 31, 2019 -120.87 Mn
Dec 31, 2018 109.84 Mn
Sep 30, 2018 -88.44 Mn
Jun 30, 2018 -55.69 Mn
Mar 31, 2018 -28.70 Mn
Dec 31, 2017 81.02 Mn
Sep 30, 2017 9.58 Mn
Jun 30, 2017 -54.60 Mn
Mar 31, 2017 -47.89 Mn
Dec 31, 2016 43.07 Mn
Sep 30, 2016 47.23 Mn
Jun 30, 2016 21.01 Mn
Mar 31, 2016 -40.67 Mn
Dec 31, 2015 -26.16 Mn
Sep 30, 2015 573,000.00
Jun 30, 2015 17.23 Mn
Mar 31, 2015 30.87 Mn
Dec 31, 2014 -36.32 Mn
Sep 30, 2014 -22.60 Mn
Jun 30, 2014 -9.00 Mn
Mar 31, 2014 5.21 Mn
Dec 31, 2013 -12.78 Mn
Sep 30, 2013 -19.87 Mn
Jun 30, 2013 -9.77 Mn
Mar 31, 2013 -14.87 Mn
Dec 31, 2012 -6.53 Mn
Sep 30, 2012 -820,000.00
Jun 30, 2012 -20.54 Mn
Mar 31, 2012 -12.68 Mn
Dec 31, 2011 341,000.00
Sep 30, 2011 4.08 Mn
Jun 30, 2011 10.02 Mn
Dec 31, 2010 20.47 Mn